Add your Event List View →

Events Calendar (May 2024)

April 1 May 2 June July 1 August September October November December January February March
 
May
Monday Tuesday Wednesday Thursday Friday Saturday Sunday
30
1
2
3
4
5
6
7
8
The London Biotechnology Show 2024

The London Biotechnology Show 2024

Biotech Revolutionises Healthcare: Explore Cutting-Edge Solutions at London Biotechnology Show 2024

Throughout history, humanity's quest for healing has undergone an extraordinary evolution. From ancient remedies sourced from nature to chemically synthesized pharmaceuticals, each phase brought progress but also suffered from limitations. Traditional medicines often provided relief without addressing the core of complex diseases, leaving patients with symptomatic relief and sometimes severe side effects.

In this ever-evolving landscape of healthcare, biotechnology heralds a transformative shift. It harnesses the living essence of organisms, cells, and biological systems to pioneer cutting-edge therapies. Unlike its predecessors, biotechnological marvels offer precision and efficacy, tailoring treatments to the individual, thereby embracing the concept of personalized medicine.

The realm of biotechnology in healthcare is vast and profound, encompassing a spectrum of innovations. Gene and Cell Therapies delve into the genetic origins of diseases, aiming to rectify anomalies at their very source. Nutraceuticals blur the lines between nutrition and pharmaceuticals, unlocking therapeutic potentials beyond sustenance alone. Biocompatible materials, meticulously engineered at the molecular level, promise transformative solutions for injuries and chronic ailments. Bioinformatics employs computational prowess to decipher biological data, illuminating pathways in drug discovery and personalized care.

These groundbreaking interventions herald a revolution in healthcare, promising not just treatment but holistic well-being. Looking ahead, the horizon of biotechnology knows no bounds. From the precision of CRISPR gene editing to the audacity of bioengineered organs, the future teems with possibilities that defy imagination, poised to redefine our approach to disease prevention and management.

In essence, biotechnology has unfurled a new chapter in the annals of healthcare, characterized by tailored precision once deemed unimaginable. With each stride forward, the promise of biotechnology shines brighter, illuminating a path towards collective health and prosperity.

One pivotal platform for showcasing these innovations is the London Biotechnology Show 2024, scheduled for the 8th and 9th of May at Olympia West. This premier event will host a topnotch conference and expo bringing together experts, researchers, and industry leaders to discuss the latest trends and showcase cutting-edge biotech solutions that have the potential to transform healthcare on a global scale.

The conference features a world-class lineup of speakers including Sarah Collins Commercial Director UK Health Security Agency, Judy H. Chou, Ph.D. President & CEO AltruBio Inc.,Cristina Ortega Duran Chief Digital Health Officer Global R&D/ Board Member AstraZeneca; Dr. Jose Manuel Cervera Grau, Executive Director, Eli Lilly and Company; Emina Atlagic, Bioinformatics Analyst, Roche; Michael D. Wagener, Medical Advisor, MENARINI Group; Stefanos Theoharis, Venture partner and sector scoping committee member, Deep Science Ventures, etc. who will acquaint the gathering with latest industry developments. It will serve as an influential platform for global thought leaders to exchange profound insights, share visionary ideas, and facilitate knowledge transfer. Link to the speakers

The show's cutting-edge expo will offer attendees a firsthand experience with the newest products, services, and solutions in the medical and broader healthcare industries. This exhibition will serve as a platform for manufacturers, innovators, solution providers, and startups to showcase their pioneering offerings and futuristic technologies that are reshaping the landscape of Biotechnology.

With the tremendous response from the entire value chain and participation of companies like Discovery Park, Acrobiosystems, EPM Scientific, AstraZeneca, Eli Lilly and Company, Roche, MENARINI Group, Deep Science, BIVDA, BIA, AGilent technologies, Merck Life science, ONE NUCLEUS, DHACA, Aramex, Abzu, etc. this event is poised to be a game-changer in the realm of biotechnology. Link to the exhibitors

 

Join us in expanding the horizons of biotech solutions, reaching beyond boundaries. For more information, reach out to us at press@valiantandcompany.com

9
The London Biotechnology Show 2024

The London Biotechnology Show 2024

Biotech Revolutionises Healthcare: Explore Cutting-Edge Solutions at London Biotechnology Show 2024

Throughout history, humanity's quest for healing has undergone an extraordinary evolution. From ancient remedies sourced from nature to chemically synthesized pharmaceuticals, each phase brought progress but also suffered from limitations. Traditional medicines often provided relief without addressing the core of complex diseases, leaving patients with symptomatic relief and sometimes severe side effects.

In this ever-evolving landscape of healthcare, biotechnology heralds a transformative shift. It harnesses the living essence of organisms, cells, and biological systems to pioneer cutting-edge therapies. Unlike its predecessors, biotechnological marvels offer precision and efficacy, tailoring treatments to the individual, thereby embracing the concept of personalized medicine.

The realm of biotechnology in healthcare is vast and profound, encompassing a spectrum of innovations. Gene and Cell Therapies delve into the genetic origins of diseases, aiming to rectify anomalies at their very source. Nutraceuticals blur the lines between nutrition and pharmaceuticals, unlocking therapeutic potentials beyond sustenance alone. Biocompatible materials, meticulously engineered at the molecular level, promise transformative solutions for injuries and chronic ailments. Bioinformatics employs computational prowess to decipher biological data, illuminating pathways in drug discovery and personalized care.

These groundbreaking interventions herald a revolution in healthcare, promising not just treatment but holistic well-being. Looking ahead, the horizon of biotechnology knows no bounds. From the precision of CRISPR gene editing to the audacity of bioengineered organs, the future teems with possibilities that defy imagination, poised to redefine our approach to disease prevention and management.

In essence, biotechnology has unfurled a new chapter in the annals of healthcare, characterized by tailored precision once deemed unimaginable. With each stride forward, the promise of biotechnology shines brighter, illuminating a path towards collective health and prosperity.

One pivotal platform for showcasing these innovations is the London Biotechnology Show 2024, scheduled for the 8th and 9th of May at Olympia West. This premier event will host a topnotch conference and expo bringing together experts, researchers, and industry leaders to discuss the latest trends and showcase cutting-edge biotech solutions that have the potential to transform healthcare on a global scale.

The conference features a world-class lineup of speakers including Sarah Collins Commercial Director UK Health Security Agency, Judy H. Chou, Ph.D. President & CEO AltruBio Inc.,Cristina Ortega Duran Chief Digital Health Officer Global R&D/ Board Member AstraZeneca; Dr. Jose Manuel Cervera Grau, Executive Director, Eli Lilly and Company; Emina Atlagic, Bioinformatics Analyst, Roche; Michael D. Wagener, Medical Advisor, MENARINI Group; Stefanos Theoharis, Venture partner and sector scoping committee member, Deep Science Ventures, etc. who will acquaint the gathering with latest industry developments. It will serve as an influential platform for global thought leaders to exchange profound insights, share visionary ideas, and facilitate knowledge transfer. Link to the speakers

The show's cutting-edge expo will offer attendees a firsthand experience with the newest products, services, and solutions in the medical and broader healthcare industries. This exhibition will serve as a platform for manufacturers, innovators, solution providers, and startups to showcase their pioneering offerings and futuristic technologies that are reshaping the landscape of Biotechnology.

With the tremendous response from the entire value chain and participation of companies like Discovery Park, Acrobiosystems, EPM Scientific, AstraZeneca, Eli Lilly and Company, Roche, MENARINI Group, Deep Science, BIVDA, BIA, AGilent technologies, Merck Life science, ONE NUCLEUS, DHACA, Aramex, Abzu, etc. this event is poised to be a game-changer in the realm of biotechnology. Link to the exhibitors

 

Join us in expanding the horizons of biotech solutions, reaching beyond boundaries. For more information, reach out to us at press@valiantandcompany.com

American Spatial Biology Congress

American Spatial Biology Congress

Following the success of our International Spatial Biology Congress: Europe for the last 2 years, we are delighted to be hosting a Spatial Biology event in America. In this rapidly developing field, spatial biology provides significant potential for creating novel clinical insights. Recent technological advancements in spatial biology have provided insights into new strategies to prevent and treat disease, particularly the interactions between the tumour and the tumour microenvironment in cancers to target patients to more specific treatments. New spatial research has focused more on the analysis of the transcriptome, epigenome, and metabolomics as well as gene and protein expression to discover how these influence cellular and molecular distributions and interactions.

With a single track over two days, featuring more than 30 presentations, you will discover the latest developments in spatial omics and techniques, bioinformatics, and spatial biology data analysis, as well as the application of spatial biology to disease and drug development. There will also be a dynamic exhibition room filled with providers showcasing their spatial technologies with ample networking opportunities, an interactive panel discussion, roundtables, and a poster competition.

10
 
American Spatial Biology Congress

American Spatial Biology Congress

Following the success of our International Spatial Biology Congress: Europe for the last 2 years, we are delighted to be hosting a Spatial Biology event in America. In this rapidly developing field, spatial biology provides significant potential for creating novel clinical insights. Recent technological advancements in spatial biology have provided insights into new strategies to prevent and treat disease, particularly the interactions between the tumour and the tumour microenvironment in cancers to target patients to more specific treatments. New spatial research has focused more on the analysis of the transcriptome, epigenome, and metabolomics as well as gene and protein expression to discover how these influence cellular and molecular distributions and interactions.

With a single track over two days, featuring more than 30 presentations, you will discover the latest developments in spatial omics and techniques, bioinformatics, and spatial biology data analysis, as well as the application of spatial biology to disease and drug development. There will also be a dynamic exhibition room filled with providers showcasing their spatial technologies with ample networking opportunities, an interactive panel discussion, roundtables, and a poster competition.

11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
<< April June >>

← Back to List of Events